Artificial Intelligence and Neuro-Medicine: Emerging Trends in Bipolar Disorder, Glioblastoma and Alzheimer’s Disease

Authors: Pandey S

DOI: 10.23880/nnoaj-16000178

Volume 8, Issue 2

Abstract

Dissecting the intricate “neuro-immune cross-talks” in the complex etiopathogenesis of neurological disorders primarily bipolar disorder, glioblastoma and Alzheimer’s disease in genetically disparate susceptible cohorts of heterogeneous population-pools by amalgamating precision-based therapeutic targeting of Ceramide-Wnt/ Frizzled-Toll like receptors-autophagy biochemical/ metabolic signaling cascades with Artificial Intelligence (AI) offers fascinating healthcare management avenues in eventual pragmatic, evidence-based predictive biomarker development in the Covid-vaccination era [1-4].

Keywords: Etiopathogenesis; Neurological Disorders; Alzheimer’s Disease; Neurons

View PDF